Tag Archives: Jonathan Kerr

Responses in BMJ to Prof Sharpe on PACE trial

 Pressure grows on Lancet to review “flawed” PACE trial On 22 August Ingrid Torjesen  wrote a news item in the British Medical Journal about an article in the Times which highlighted the call to review the results of the PACE trial into … Continue reading

Posted in News | Tagged , , , , , , , | Comments Off on Responses in BMJ to Prof Sharpe on PACE trial

ME/CFS in Colombian workers

Research abstract: Background: Chronic Fatigue Syndrome/Myalgic encephalomyelitis (CFS/ME) is a debilitating and complex disease characterised by intense fatigue and a variety of other symptoms, which are present for at least 6 months. Studies of CFS/ME in the working population are … Continue reading

Posted in News | Tagged , , , | Comments Off on ME/CFS in Colombian workers

MicroRNAs as potential biomarkers in ME/CFS

ME Research UK comments on recent research: MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME), by RD Petty, NE McCarthy, R Le Dieu, J R … Continue reading

Posted in News | Tagged , , , , , | Comments Off on MicroRNAs as potential biomarkers in ME/CFS

Potential diagnostic biomarkers in Natural Killer cells of patients with CFS/ ME

Research abstract: BACKGROUND: Chronic Fatigue Syndrome (CFS/ME) is a complex multisystem disease of unknown aetiology which causes debilitating symptoms in up to 1% of the global population. Although a large cohort of genes have been shown to exhibit altered expression … Continue reading

Posted in News | Tagged , , , | Comments Off on Potential diagnostic biomarkers in Natural Killer cells of patients with CFS/ ME